Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icl (ICL) Cash & Equivalents (2016 - 2026)

Icl has reported Cash & Equivalents over the past 11 years, most recently at $407.0 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 30.45% year-over-year to $407.0 million; the TTM value through Mar 2026 reached $407.0 million, up 30.45%, while the annual FY2025 figure was $291.0 million, 11.01% down from the prior year.
  • Cash & Equivalents was $407.0 million for Q1 2026 at Icl, up from $291.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $420.0 million in Q4 2023 and bottomed at $291.0 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $367.0 million (2024), against an average of $362.3 million.
  • Year-over-year, Cash & Equivalents fell 22.14% in 2024 and then surged 30.45% in 2026.
  • Over 5 years, Cash & Equivalents stood at $417.0 million in 2022, then grew by 0.72% to $420.0 million in 2023, then fell by 22.14% to $327.0 million in 2024, then dropped by 11.01% to $291.0 million in 2025, then skyrocketed by 39.86% to $407.0 million in 2026.
  • The last three reported values for Cash & Equivalents were $407.0 million (Q1 2026), $291.0 million (Q4 2025), and $312.0 million (Q1 2025) per Business Quant data.